Stockscreener 앱 받기
56.93
0.54%
-0.31
시장 영업 전:
56.82
-0.11
-0.19%
Vaxcyte Inc 주식(PCVX)의 최신 뉴스
Jennison Associates LLC Has $31.26 Million Stock Position in Vaxcyte, Inc. $PCVX - MarketBeat
Vaxcyte's Manufacturing-Backed Vaccine Platform Is Redefining The PCV Market - Seeking Alpha
Vaxcyte COO Jim Wassil sells $127,869 in PCVX shares By Investing.com - Investing.com Canada
Insider Sell Alert: Jim Wassil Sells Shares of Vaxcyte Inc (PCVX) - GuruFocus
Vaxcyte (NASDAQ:PCVX) COO Sells $127,867.50 in Stock - MarketBeat
Vaxcyte COO Jim Wassil sells $127,869 in PCVX shares - Investing.com
Vaxcyte (PCVX) COO Jim Wassil sells 2,250 shares in Rule 10b5-1 trade - Stock Titan
PCVX (PCVX) insider James Wassil files planned sales totaling $566,913.91 - Stock Titan
Vaxcyte Executive Compensation, Directors, and Corporate Governance Overview 2025 - Minichart
Universal Beteiligungs und Servicegesellschaft mbH Raises Stake in Vaxcyte, Inc. $PCVX - MarketBeat
Vanguard (PCVX) holds 7.25M Vaxcyte shares, reports 5.03% stake - Stock Titan
Pictet Asset Management Holding SA Has $40.67 Million Stock Position in Vaxcyte, Inc. $PCVX - MarketBeat
Vaxcyte (PCVX) Expected to Announce Quarterly Earnings on Wednesday - MarketBeat
Vaxcyte, Inc. (PCVX) Stock Analysis: Exploring the 83% Potential Upside in Vaccine Innovation - DirectorsTalk Interviews
Vaxcyte, Inc. (NASDAQ:PCVX) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat
Vaxcyte launches proposed $500M public offering of stock, warrants - MSN
Vaxcyte Completes Enrollment for Phase 3 VAX-31 Vaccine Trials - HarianBasis.co
[ARS] Vaxcyte, Inc. SEC Filing - Stock Titan
Vaxcyte (NASDAQ: PCVX) 2026 proxy on directors, auditor and say-on-pay - Stock Titan
Vaxcyte Inc (PCVX)’s VAX-31 Enters Critical Trial Stage - Insider Monkey
5 Best 52-Week High US Stocks to Buy - Insider Monkey
Trading Systems Reacting to (PCVX) Volatility - Stock Traders Daily
InvestingPro Fair Value predicted Vaxcyte’s 36% decline By Investing.com - Investing.com South Africa
Vaxcyte, Inc. (PCVX) Investor Outlook: A Deep Dive Into Its 74.82% Upside Potential - DirectorsTalk Interviews
Vaxcyte (NASDAQ:PCVX) Stock Rating Upgraded by Wall Street Zen - MarketBeat
Insiders At Vaxcyte Sold US$1.0m In Stock, Alluding To Potential Weakness - 富途牛牛
Needham Maintains Vaxcyte(PCVX.US) With Buy Rating, Maintains Target Price $110 - Moomoo
Vaxcyte (PCVX) Stock Insider Selling (Edges Lower) 2026-04-15Large Cap Trends - Cổng thông tin điện tử tỉnh Tây Ninh
PCVX Q4 2025 Earnings: Vaxcyte Inc. Misses EPS Estimates, Reports No RevenueExpert Market Insights - UBND thành phố Hải Phòng
PCVX Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Vaxcyte (NASDAQ:PCVX) Stock Rating Lowered by Wall Street Zen - MarketBeat
How Vaxcyte Inc. (PCVX) Affects Rotational Strategy Timing - Stock Traders Daily
Is It Too Late To Consider Vaxcyte (PCVX) After A 95% One-Year Share Price Jump? - Yahoo Finance
What is the target price for Vaxcyte Inc stock2026 Momentum Check & AI Forecasted Entry/Exit Points - baoquankhu1.vn
PCVX SEC FilingsVaxcyte, Inc. 10-K, 10-Q, 8-K Forms - Stock Titan
Vaxcyte CAO Sells $180,000 in Company Stock - National Today
Vaxcyte CAO Sells $180,000 in Stock - National Today
Insider Selling: Vaxcyte (NASDAQ:PCVX) CAO Sells 3,000 Shares of Stock - MarketBeat
Vaxcyte (PCVX) finance chief sells 3,000 shares after option exercise - Stock Titan
Vaxcyte to Present at Annual Healthcare Conference - National Today
Vaxcyte Inc stock: Why its pneumococcal vaccine pipeline draws investor focus - AD HOC NEWS
Vaxcyte to Present at the 25th Annual Needham Virtual Healthcare Conference - Sahm
Elvia Cowan registers 3,000-share sale (PCVX) after option exercise - Stock Titan
Vaxcyte (PCVX) Stock Analysis Report | Financials & Insights - Benzinga Japan
Vaxcyte, Inc. (PCVX) Investor Outlook: An 86.71% Potential Upside Raises Eyebrows - DirectorsTalk Interviews
Aberdeen Group plc Increases Holdings in Vaxcyte, Inc. $PCVX - MarketBeat
PCVX.O Technical Analysis & Stock Price Forecast - Intellectia AI
PCVX Should I Buy - Intellectia AI
2.45%
자본화:
|
볼륨(24시간):